Persistent Asset Partners LTD Nuvalent, Inc. Transaction History
Persistent Asset Partners LTD
- $121 Billion
- Q4 2024
A detailed history of Persistent Asset Partners LTD transactions in Nuvalent, Inc. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 4,435 shares of NUVL stock, worth $355,953. This represents 0.32% of its overall portfolio holdings.
Number of Shares
4,435Holding current value
$355,953% of portfolio
0.32%Shares
1 transactions
Others Institutions Holding NUVL
# of Institutions
231Shares Held
58.9MCall Options Held
834KPut Options Held
490K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.44 Billion34.87% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.36MShares$430 Million16.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.5MShares$361 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$243 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY2.62MShares$210 Million6.84% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.45B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...